We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Non-Invasive Diagnostics of Renal Cell Carcinoma Using Ultrasensitive Immunodetection of Cancer-Retina Antigens.
- Authors
Shlyapnikov, Yuri M.; Malakhova, Ekaterina A.; Potoldykova, Natalia V.; Svetocheva, Yana A.; Vinarov, Andrei Z.; Zinchenko, Dmitry V.; Zernii, Evgeni Yu.; Zamyatnin Jr., Andrey A.; Shlyapnikova, Elena A.
- Abstract
Renal cell carcinoma (RCC) is the most common urological malignancy with a high mortality and low detection rate. One of the approaches to improving its diagnostics may be the search for new non-invasive biomarkers in liquid biopsy and development of more sensitive methods for their detection. Cancer-retina antigens, which are known to be aberrantly expressed in malignant tumors, are present in liquid biopsy at extremely low concentrations. Using the developed multiplex immunoassay with a detection limit of 0.1 pg/ml, urine and serum samples of 89 patients with RCC and 50 non-cancer patients were examined for the presence of cancer-retina antigens (arrestin, recoverin, rhodopsin kinase, and transducin); the difference between the RCC and control groups was evaluated with the χ2 test. The results showed high diagnostic efficiency of a combination of arrestin and recoverin: at a threshold of 0.1 pg/ml, the sensitivity was 96%, specificity 92%, and AUC = 0.96 (95% confidence interval, 0.93-0.99). Seven days after nephrectomy, the concentration of the antigens returned to the level characteristic of the control group. Therefore, arrestin in a combination with recoverin can serve as a diagnostic non-invasive urinary biomarker of RCC.
- Subjects
RENAL cell carcinoma; ANTIGENS; ARRESTINS; RETINA; DETECTION limit; RHODOPSIN
- Publication
Biochemistry (00062979), 2022, Vol 87, Issue 7, p658
- ISSN
0006-2979
- Publication type
Article
- DOI
10.1134/S0006297922070070